PL197005A1 - Sposob wytwarzania nowych pochodnych prostaglandyn - Google Patents

Sposob wytwarzania nowych pochodnych prostaglandyn

Info

Publication number
PL197005A1
PL197005A1 PL19700577A PL19700577A PL197005A1 PL 197005 A1 PL197005 A1 PL 197005A1 PL 19700577 A PL19700577 A PL 19700577A PL 19700577 A PL19700577 A PL 19700577A PL 197005 A1 PL197005 A1 PL 197005A1
Authority
PL
Poland
Prior art keywords
making new
prostaglandin derivatives
new prostaglandin
derivatives
making
Prior art date
Application number
PL19700577A
Other languages
English (en)
Other versions
PL107643B1 (pl
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz filed Critical Labaz
Publication of PL197005A1 publication Critical patent/PL197005A1/pl
Publication of PL107643B1 publication Critical patent/PL107643B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms
    • C07C53/128Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
PL1977197005A 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandyn PL107643B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL49325A IL49325A (en) 1976-03-31 1976-03-31 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
PL197005A1 true PL197005A1 (pl) 1978-10-09
PL107643B1 PL107643B1 (pl) 1980-02-29

Family

ID=11048789

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1977210102A PL108289B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandynmethod of producing new derivatives of prostaglandins
PL1977197005A PL107643B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandyn
PL1977210101A PL107544B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandyn

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1977210102A PL108289B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandynmethod of producing new derivatives of prostaglandins

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1977210101A PL107544B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandyn

Country Status (18)

Country Link
US (1) US4115401A (pl)
JP (1) JPS52142060A (pl)
BE (1) BE852941A (pl)
CA (1) CA1074804A (pl)
CH (2) CH624101A5 (pl)
DD (1) DD130352A5 (pl)
DE (1) DE2714129A1 (pl)
ES (1) ES457385A1 (pl)
FR (1) FR2346332A1 (pl)
GB (1) GB1574246A (pl)
HU (1) HU178040B (pl)
IL (1) IL49325A (pl)
IT (1) IT1075373B (pl)
NL (1) NL7703503A (pl)
NO (1) NO149428C (pl)
PL (3) PL108289B1 (pl)
SE (1) SE417603B (pl)
SU (3) SU676162A3 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5536475A (en) * 1978-07-11 1980-03-14 Glaxo Group Ltd Prostanoid compound
US4320136A (en) * 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4456613A (en) * 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
US4530933A (en) * 1982-12-27 1985-07-23 E. I. Du Pont De Nemours And Company 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
OA12117A (en) 1999-12-22 2006-05-04 Pfizer Prod Inc EP4 receptor selective agonists in the treatment of osteoporosis.
PT1339678E (pt) * 2000-11-27 2007-11-30 Pfizer Prod Inc Agonistas selectivos do receptor ep4 no tratamento de osteoporose
AU2002328338C1 (en) * 2001-07-16 2009-01-08 Ono Pharmaceutical Co., Ltd 2 pyrrolidone derivatives as prostanoid agonists
BR0211201A (pt) 2001-07-16 2004-07-13 Hoffmann La Roche Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero
TWI313608B (en) 2001-07-23 2009-08-21 Ono Pharmaceutical Co Lower bone mass treating agent containing er4 agonist as active ingredient
JP4547912B2 (ja) 2002-03-05 2010-09-22 小野薬品工業株式会社 8−アザプロスタグランジン誘導体化合物およびその化合物を有効成分として含有する薬剤
CA2479222A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
MXPA05007341A (es) * 2003-01-10 2005-09-30 Hoffmann La Roche Derivados de 2-piperidona como agonistas de prostaglandina.
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20080058375A1 (en) * 2004-01-08 2008-03-06 Elworthy Todd R 2-Piperidone derivatives as prostaglandin antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones

Also Published As

Publication number Publication date
JPS52142060A (en) 1977-11-26
SE7703698L (sv) 1977-10-01
SU676162A3 (ru) 1979-07-25
IT1075373B (it) 1985-04-22
CA1074804A (en) 1980-04-01
PL107643B1 (pl) 1980-02-29
DE2714129A1 (de) 1977-10-13
US4115401A (en) 1978-09-19
NO149428C (no) 1984-04-18
NL7703503A (nl) 1977-10-04
BE852941A (fr) 1977-09-28
CH628032A5 (fr) 1982-02-15
NO771134L (no) 1977-10-03
FR2346332B1 (pl) 1980-05-09
PL108289B1 (pl) 1980-03-31
IL49325A (en) 1979-11-30
ES457385A1 (es) 1978-02-01
HU178040B (en) 1982-02-28
SU715019A3 (ru) 1980-02-05
PL107544B1 (pl) 1980-02-29
CH624101A5 (pl) 1981-07-15
FR2346332A1 (fr) 1977-10-28
IL49325A0 (en) 1976-05-31
SE417603B (sv) 1981-03-30
DD130352A5 (de) 1978-03-22
GB1574246A (en) 1980-09-03
NO149428B (no) 1984-01-09
SU837321A3 (ru) 1981-06-07

Similar Documents

Publication Publication Date Title
PL195997A1 (pl) Sposob wytwarzania nowych pochodnych karboksyalkiloacyloaminokwasow
PL201586A1 (pl) Sposob wytwarzania nowych zwiazkow spiro-hydantionowych
PL196505A1 (pl) Sposob wytwarzania nowych zwiazkow aminoalkiloheterocyklicznych
PL201286A1 (pl) Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow
PL197005A1 (pl) Sposob wytwarzania nowych pochodnych prostaglandyn
PL200289A1 (pl) Sposob wytwarzania zwiazkow 3-chlorocefemowych
PL215008A1 (pl) Sposob wytwarzania pochodnych piranonu-3
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL200685A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL199603A1 (pl) Sposob wytwarzania nowych pochodnych kwasu pirolokarboksylowego-1
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL193183A1 (pl) Sposob wytwarzania nowych pochodnych 11-dezoksy-16-arylo-omega-tetranorprostaglandyny
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL200124A1 (pl) Sposob wytwarzania nowych pochodnych pirolidonu
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL199364A1 (pl) Sposob wytwarzania nowych pochodnych benzoksycyny
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL197045A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL202660A1 (pl) Sposob wytwarzania nowych pochodnych spirooksazolidynodionu
PL201133A1 (pl) Sposob wytwarzania nowych pirydobenzodwuazepinonow
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy